Список литературы

    1. Балашевич Л.И., Измайлов А.С. Диабетическая офтальмопатия. - СПб.: Человек, 2012. - 336 с.

    2. Большунов А.В., Зиангирова Г.Г., Калинкин А.В. и др. К вопросу о возможном механизме лечебного воздействия метода лазерной коагуляции сетчатки // Междунар. симпоз.: Тез. докл. - Самарканд, 1988. - С. 345-346.

    3. Гацу М.В., Байбородов Я.В. Клинико-топографическая классификация диабетических макулопатий // Сахарный диабет. - 2008. - Т. 11. №3 - C. 20-22.

    4. Деуфраинс А., Дитце У., Юттэ А. и соавт. Световая коагуляция в лечении диабетической ретинопатии // Вестник офтальмологии. - 1980. - №2. - С. 28-31.

    5. Желтов Г.И., Романов Г.С., Романов О.Г., Иванова Е.В. Селективное действие лазерных импульсов на ретинальный пигментный эпителий. Физические основы // Новое в офтальмологии. – 2012. - №3. – С. 37-43.

    6. Иванишко А. Новая классификация диабетических макулопатий (ДМП), адаптированная к проблематике их лазерного лечения // Евро-Азиатская конф. по офтальмохирургии 2-я: Тез. докл., Екатеринбург, 2001. – С. 174 –175.

    7. Измайлов А.С., Балашевич Л.И. Клиническая классификация диабетической ретинопатии // Офтальмохирургия и терапия. - 2002. - Т. 2. № 1-2. - С. 26-32.

    8. Качалина ГФ, Павлова ЕС. Субпороговая аргоновая коагуляция сетчатки в лечении очаговой диабетической макулопатии // Офтальмохирургия. - 2004. -№3. - С. 43-46.

    9. Клепинина О.Б. Субпороговое микроимпульсное лазерное воздействие длиной волны 577 нм при лечении центральной серозной хориоретинопатии: Дис. … к-та мед. наук. – М., 2014. – 143 с.

    10. Коцур Т.В., Измайлов А.С. Анализ эффективности лазерной коагуляции в макуле и микрофотокоагуляции высокой плотности в лечении диабетической макулопатии // Вестник Оренбургского государственного университета. - 2013. - Т.4, № 2. - С. 150-152.

    11. Краснов М.М., Сапрыкин П.И., Доронин П.П. и соавт. Электронно-микроскопическое изучение тканей глазного дна при лазерной коагуляции // Вестник офтальмологии. - 1973. - Т. 89, № 2. - С. 13-15.

    12. Куранова О.И. Изучение эффективности микроимпульсного лазерного воздействия длиной волны 577 нм при макулярном отеке после хирургического удаления идиопатической эпиретинальной мембраны: Дис. … к-та мед. наук. – М., 2014. – 138 с.

    13. Липатов Д.В., Александрова В.К., Атарщиков Д.С. и др. Эпидемиология и регистр диабетической ретинопатии в Российской Федерации // Сахарный диабет. - 2014. - №1. - С. 4-7.

    14. Мазунин И.Ю., Нероев В.В. Субпороговое микроимпульсное инфракрасное воздействие широким пятном при лечении диабетического макулярного отека. // Здравоохранение Российской Федерации. - 2010. - №5. - С. 41-43.

    15. Патент РФ № 2308920. Способ модифицированной субпороговой панмакулярной микрофотокоагуляции сетчатки при диабетическом макулярном отеке / Балашевич Л.И., Чиж Л.В., Гацу М.В.; Заявитель и патентообладатель ФГУ «МНТК «Микрохирургия глаза» им. акад. С.Н. Федорова Минздрава России»; Заявл. 04.10.2005 г.

    16. Педанова Е.К. Микропериметрия в оценке функционального состояния и комплексном прогнозировании результатов хирургического лечения пациентов с идиопатическим макулярным разрывом: Дис. … к-та мед. наук. – М., 2009. – 136 с.

    17. Сизова М.В. Плазмаферез в комплексном лечении диабетического макулярного отека: Дис. … к-та мед. наук. – М., 2011. – 130 с.

    18. Федорук Н.А., Федоров А.А., Большунов А.В. Патоморфологические и гистохимические проявления взаимодействия лазерного излучения с тканями хориоретинального комплекса (обзор литературы) // Вестник офтальмологии. -2009. - № 3. - С. 61-64.

    19. Ходжаев Н.С., Черных В.В., Роменская И.В. и соавт. Влияние лазерокоагуляции сетчатки на клинико-лабораторные показатели у пациентов диабетическим макулярным отеком // Вестник НГУ. - 2011. - Т. 9, №4. - C. 48- 53.

    20. Aiello L.M. Principes and practice of ophthalmology // Diagnosis, management, and treatment of nonproliferative diabetic retinopathy and macular edema / Ed. by Albert D.M. and Jakobiec F.A. - Philadelphia: W.B. Saunders Company, 1994. - Vol. 2. - P. 747-760.

    21. Aiello L.P., Northrup J.M., Keyt B.A. et al. Hypoxie regulation of vascular endothelial growth factor in retinal cells // Arch Ophthalmol. - 1995. - Vol. 113. - P. 1538-1544.

    22. Ambati J., Chalam K.V., Chawla D.K. et al. Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy // Arch. Ophthalmol. 1997. Vol. 115. -P. 1161 – 1166.

    23. Antcliff R.J., Marshall J. The pathogenesis of edema in diabetic maculopathy // Semin Ophthalmol. - 1999. - Vol. 14. - P. 223-232.

    24. Antonetti D.A., Barber A.J., Hollinger L.A. et al. Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occludens 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors // J Biol Chem. - 1999. - Vol. 274, № 33. - P. 23463-23467.

    25. Bailey T.A., Kanuga N., Romero I.A. et al. Oxidative stress affects the junctional integrity of retinal pigment epithelial cells // Invest. Ophthalmol. Vis. Sci. - 2004. -Vol. 45. - P. 675 –684.

    26. Ban Y., Rizzolo L.J. Differential regulation of tight junction permeability during development of the retina, pigment epithelium // American Journal of Physiology. -2000. - Vol. 279, № 3. - P. C744 –C750.

    27. Bandello F., Polito A., Del Borrello M., Zemella N., Isola M. "Light" versus "classic" laser treatment for clinically significant diabetic macular oedema // B J Ophthalmol. - 2005. - Vol. 89, № 7. - P. 864 –870.

    28. Barber A., Lieth E., Khin S. et al. Neural apoptosis in the retina during experimental and human diabetes: early onset and effect of insulin // J Clin Invest. -1998. - Vol. 102. - P. 783-791.

    29. Barber A.J. A new view of diabetic retinopathy: a neurodegenerative disease of the eye // Prog Neuropsychopharmacol Biol Psychiatry. - 2003. - Vol. 27. -P. 283 – 290.

    30. Barber A.J., Antonetti D.A. Mapping the blood vessels with paracellular permeability in the retinas of diabetic rats // Invest Ophthalmol Vis Sei. - 2003. - Vol. 44. - P. 5410-541б.

    31. Barber A.J., Antonetti D.A., Gardner T.W. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Perm State Retina Research Group // Invest Ophthalmol Vis Sei. - 2000. - Vol. 41. - P. 3561-3568.

    32. Baydas G., Tuzcu M., Yasar A., Baydas B. Early changes in glial reactivity and lipid peroxidation in diabetic rat retina: effects of melatonin // Acta Diabetol. - 2004. - Vol. 1. - P. 123-128.

    33. Bennett S.R., Folk J.C., Blodi C.R et al. Factors prognostic of visual outcome in patients with subretinal hemorrhage // Amer. J. OphthalmoL. - 1990. - Vol. 109, № l. - P. 33-37.

    34. Bhagat N., Grigorian R.A., Tutela A., Zarbin M.A. Diabetic macular edema: pathogenesis and treatment // Surv Ophthalmol. - 2009. - Vol. 50. - P. 1-20.

    35. Bille J.F., Dreher G.W., Zinser G. Scanning laser tomography of the living human eye // Noninvasive Diagnostic Techniques in Ophthalmology. New York: Springer-Verlag. - 1990. - P. 528-547.

    36. Bok D. The retinal pigment epithelium: a versatile partner in vision // Journal of Cell Science. - 1993. - Vol. 17. - P. 189 –195.

    37. Bresnick G.H. Diabetic macular edema // Ophthalmology. - 1986. - Vol. 73, № 7. - P. 989-997.

    38. Bresnick G.H. Diabetic maculopathy. A critical review highlighting diffuse macular edema // Ophthalmology. - 1983. - Vol. 90, № 11. - P. 1301-1317.

    39. Bresnick G.H. Diabetic retinopathy viewed as a neurosensory disorder // Arch Ophthalmol. - 1986. - Vol. 104. - P. 989 –990.

    40. Bringmann A., Pannicke T., Biedermann B. et al., Role of retinal glial cells in neurotransmitter uptake and metabolism // Neurochemistry International. - 2009. -Vol. 54, №. 3-4. - P. 143 –160.

    41. Bringmann A., Pannicke T., Grosche J. et al. Muller cells in the healthy and diseased retina // Progress in Retinal and Eye Research. - 2006. - Vol. 25, № 4. - P. 397 –424.

    42. Bringmann A., Reichenbach A., Wiedermann P. Pathomechanisms of cystoid macular edema // Ophthalmic Res. - 2004. - Vol. 39. - P. 241-249.

    43. Bringmann A., Wiedemann P. Muller glial cells in retinal disease // Ophthalmologica, - 2012. - Vol. 227, №1. - P. 1 –19.

    44. Brown J.C., Solomon S.D., Bressler S.B. et al. Detection of diabetic foveal edema. Contact lens biomicroscopy compared with optical coherence tomography // Arch Ophthalmol. - 2004. - Vol. 122. - P. 330-335.

    45. Canataroglu H., Varinli I., Ozcan A.A. et al. Interleukin (IL)-6, interleukin (IL)-8 levels and cellular composition of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy // Ocul Immunol Inflamm. - 2005. - Vol. 13. - P.375-381.

    46. Charanjit K., Foulds W.S., Ling E.-A. Hypoxia-ischemia and retinal ganglion cell damage // Clin. Ophthalmol. - 2008. - Vol.2, № 4. - P. 879 –889.

    47. Chong V. Basic principles of micropulse laser and difference to other subthreshold techniques // Proceedings of the 14th Euretina Congress, Instructional Course 18, Congress Materials. - London, UK, 2014.

    48. Crider J.Y., Yorio T., Sharif N.A., Griffin B.W. The effects of elevated glucose on Na+/K+-ATPpase of cultured bovine retinal pigment epithelial cells measured by a new nonradioactive rubidium uptake assay // Journal of Ocular Pharmacology and Therapeutics. - 1997. - Vol. 13, № 4. - P. 337 –352.

    49. Cunha-Vaz J.G., Shakib M., Ashton N. Studies on the permeability of the bloodretinal barrier. I. On the existence, development and site of blood-retinal barrier // Br J Ophthamol. - 1966. - Vol. 50. - P. 441-453.

    50. Curtis T.M., Hamilton R., Yong P.-H. et al. Muller glial dysfunction during diabetic retinopathy in rats is linked to accumulation of advanced glycation endproducts and advanced lipoxidation end-products // Diabetologia. - 2010. - P. 690-698

    51. Dam van P.S. Oxidative stress and diabetic neuropathy: pathophysiological mechanisms and treatment perspectives // Diabetes Metab Res Rev. - 2002. - Vol. 18. - P. 17б-184.

    52. Dawson D.W., Volpert O.V., Gillis P. et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis // Science. - 1999. - Vol. 285. - P. 245-248.

    53. Deak G.G., Bolz M., Ritter M. et al. A systematic correlation between morphology and functional alterations in diabetic macular edema // Invest Ophthalmol Vis Sci. - 2010. - Vol. 51. - P. 6710 –6714.

    54. Decanini A., Karunadharma P.R., Nordgaard C.L. et al. Human retinal pigment epithelium proteome changes in early diabetes // Diabetologia. - 2008. - Vol. 51, № 6. - P. 1051 –1061.

    55. Diabetes Control and Complication Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complication in insulin dependent diabetes mellitus // N. Engl. J. Med. - 1993. - Vol. 329. - P. 977 –986.

    56. Diabetes Control and Complication Trial Research Group. The relationship of glycemic exposure (HbA1с) to the risk of development and progression of retinopathy in the Diabetes Control and Complication Trial // Diabetes. - 1995. - Vol. 44. - P. 968 – 983.

    57. Diabetic Retinopathy Clinical Research Network, Elman M.J., Qin H. et al. Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results // Ophthalmology. - 2012. - Vol. 119, № 11. - P. 2312-2318.

    58. Diabetic Retinopathy Clinical Research Network. Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema // Ophthalmology. - 2007. - Vol. 114. - P. 525 –536.

    59. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study (ETDRS) report No 1 // Arch. Ophthalmol. - 1985. - Vol. 103. - P. 1796-1806.

    60. Early Treatment Diabetic Retinopathy Study Research Group. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study (ETDRS) report No 2. // Ophthalmology. - 1987. - Vol. 94, № 7. - P. 761-774.

    61. Er H., Doganay S., Turkoz Y. The levels of cytokines and nitric oxide in rabbit vitreous humor after retinal laser photocoagulation // Ophthalmic Surg Lasers. - 2000. - Vol. 31, №6. - P. 479 –483.

    62. Erickson K.K., Sundstrom J.M., Antonetti D.A. Vascular permeability in ocular disease and the role of tight junctions // Angiogenesis. - 2007. - Vol. 10. - P.103-117.

    63. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress // Endocr Rev. - 2004. - Vol. 24. - P. 581-611.

    64. Figueira J., Khan J., Nunes S., Sivaprasad S. et al. Prospective randomised controlled trial comparing sub-threshold micropulse diode laser photocoagulation and conventional green laser for clinically significant diabetic macular oedema // Br J Ophthalmol. - 2009. - Vol. 93, № 10. - P. 1341-1314.

    65. Finnemann S.C. Focal adhesion kinase signaling promotes phagocytosis of integrin-bound photoreceptors // The EMBO Journal. - 2003. - Vol. 22, № 16. - P 4143 –4154.

    66. Forooghian F., Stetson P.F., Meyer S.A. et al. Relationship between photoreceptor outer segment length and visual acuity in diabetic macular edema // Retina. - 2010. - Vol. 30, № 1. - P. 63 –70.

    67. Funatsu H., Yamashita H., Nakamura S. et al. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema // Ophthalmology. - 2006. - Vol. 11З. - P. 294-301.

    68. Gao G., Li Y., Gee S. et al. Down-regulation of VEGF and upregulation of PEDF: a possible mechanism for the anti-angiogenic activity of plasminogen kringle 5 // J Biol Chem. - 2002. - Vol. 277. - P. 9492-9499.

    69. Gao G., Li Y., Zhang D. et al. Unbalanced expression of VEGF and PEDF in ischemia-induced retinopathy // FEES Lett. - 2001. - Vol. 489. - P. 270-276.

    70. Gao X., Xing D. Molecular mechanisms of cell proliferation induced by low power laser irradiation // J Biomed Sci. 2009. - Vol. 16, № 1. - P. 1-16.

    71. Garcia-Ramirez C., Hernandez C., Villarroel M., et al. Interphotoreceptor retinoid-binding protein (IRBP) is downregulated at early stages of diabetic retinopathy // Diabetologia. - 2009. - Vol. 52, № 12. - P. 2633 –2641.

    72. Gardiner T.A., Anderson H.R., Stitt A.W. Inhibition of advanced glycation endproducts protects against retinal capillary basement membrane expansion during longterm diabetes // J Pathol. - 2003. - Vol. 201. - P. 328 –333.

    73. Gardner T.W., Antonetti D.A., Barber A.J., LaNoue K.F, Levison S.W. Diabetic retinopathy: more than meets the eye // Surv Ophthalmol. - 2002. - Vol. 47. - P. S253- S262.

    74. Geiger R.C., Waters C.M., Kamp D.W., Glucksberg M.R. KGF prevents oxygen-mediated damage in ARPE-19 cells // Invest. Ophthalmol. Vis. Sci. - 2005. -Vol. 46. - P. 3435 –3442.

    75. Ghazi N.G., Scruggs R.T., Batchelet A.R. et al. Diabetic macular edema. //Ophthalmology. -2012. -Vol. 119, № 12. - P. 2641-2643.

    76. Group TDCaCTR. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group // Ophthalmology. - 1995. - Vol. 102, № 4. - P. 647-61.

    77. Hammes H.P., Lin J., Bretzel R.G. et al. Upregulation of the vascular endothelial growth factor vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat // Diabetes. - 1998. - Vol. 47. - P. 401-406.

    78. Hammes H.P., Lin J., Renner O., Shani M.et al. Pericytes and the pathogenesis of diabetic retinopathy // Diabetes. - 2002. - Vol .51. - P. 3107-3112.

    79. Hammes H.-P., Porta M., editors. Experimental Approaches to Diabetic Retinopathy. - Basel: Karger, 2010. - P. 20-41.

    80. Hammes H.-P., Porta M., editors. Experimental Approaches to Diabetic Retinopathy. - Basel: Karger, 2010. - P. 109-123.

    81. Harhaj N.S., Felinski E.A., Wolpert E.B. VEGF activation of protein kinase С stimulates occludin phosphorylation and contributes to endothelial permeability. // Invest Ophthalmol Vis Sei. - 2006. - Vol. 47. - P. 5106-5115.

    82. Henkind P. Ocular neovascularization // Am J Ophthalmol. - 1978. - Vol. 85, №3. - P.287-301

    83. Holtkamp G.M., Kijlstra A., Peek R., de Vos A.F. Retinal pigment epitheliumimmune system interactions: cytokine production and cytokine-induced changes // Progress in Retinal and Eye Research. - 2001. - Vol. 20, № 1. - P. 29 –48.

    84. Hood D.C., Bach M., Brigell M. et al. International Society For Clinical Electrophysiology of Vision. ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition) // Doc Ophthalmol. - 2012. - Vol .124, № 1. - P. 1-13.

    85. Hou J., Gomes A.S., Paul D.L., Goodenough D.A. Study of claudin function by RNA interference // J Biol Chem. - 2006. - Vol. 281. - P. 36117-36123.

    86. Inagaki K., Ohkoshi K., Ohde S. Spectral-domain optical coherence tomography imaging of retinal changes after conventional multicolor laser, subthreshold micropulse diode laser, or pattern scanning laser therapy in Japanese with macular edema // Retina. - 2012. - Vol. 32, № 8. - P. 1592-1600.

    87. International Diabetes Federation. IDF Diabetes Atlas, 7 ed. - Brussels, Belgium: International Diabetes Federation. - 2015.

    88. Ishida S., Shinoda K., Kawashima S. et al. Coexpression of VEGF receptors VEGF-r² and neuropilin-1 in proliferative diabetic retinopathy // Invest Ophthalmol Vis Sei. - 2000. - Vol. 41. - P. 1649-1б56.

    89. Itaya M., Sakurai E., Nozaki M. Upregulation of VEGF in murine retina via monocyte recruitment after retinal scatter laser photocoagulation // Invest Ophthalmol Vis Sci. - 2007. - Vol. 48, №12. - P. 5677 –5683.

    90. Ivanisevic M., Striga M., Stanic R. Argon laser photocoagulation for the treatment of diabetic macular oedema. Comparative study of efficacy between focal extramacular treatment and focal macular perifoveolar treatment // Ophthalmologica. - 1992. - Vol. 205, № l. - P. 15-18.

    91. Joussen A.M., Murata T., Tsujikawa A. et al. Leukocyte-mediated endothelial cell injury and death in the diabetic retina // Am J Pathol. - 2001. - Vol 158. - P. 147-152.

    92. Joussen A.M., Poulaki V., Le M.L. et al. A central role for inflammation in the pathogenesis of diabetic retinopathy // FASEB J. - 2004. - Vol. 18. - P. 1450-1452.

    93. Joussen A.M., Smyth N., Niessen C. Pathophysiology of diabetic macular edema // Developments in Ophthalmology. - 2007. - Vol. 39. - P 1 –12.

    94. Kang H., Xu Y.S., Zhang H., Du B. Characters of multifocal electroretinogram in different grades of diabetic macular edema // Zhonghua Yan Ke Za Zhi. - 2011. -Vol. 47, № 8. - P. 709-714.

    95. Kang S.W., Park C.Y., Ham D.I. The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema // American Journal of Ophthalmology. - 2004. - Vol. 137, № 2. - P. 313-322.

    96. Keech A., Simes R.J., Barter P. et al. Effect of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial // Lancet. - 2005. - Vol. 366. - P. 1849 –1861.

    97. Kiire C., Sivaprasad S., Chong V. Subthreshold Micropulse Laser Therapy for Retinal Disorders // Retina today. – 2011. – January/February. – P.67-70.

    98. Kim J.H., Kim J.H., Jun H.O. et al. Inhibition of protein kinase C delta attenuates blood-retinal barrier breakdown in diabetic retinopathy // Am J Pathol. - 2010. - Vol. 176. - P. 1517 –1524.

    99. Kim Y.H., Kim Y.S., Roh G.S. Resveratrol blocks diabetes-induced early vascular lesions and vascular endothelial growth factor induction in mouse retinas // Acta Ophthalmol. - 2012. - Vol. 90. - P. 31 –37.

    100. Klein R., Klein B.E.K., Moss S.E. The epidemiology of ocular problems in diabetes mellitus / Feman S.S., ed. // Ocular problems in diabetes mellitus. - Boston, Blackwell. - 1992. - P. 1-52.

    101. Klein R., Klein B.E.K., Moss S.E., Cruickshanks K.J. The Wisconsin epidemiologic study of diabetic retinopathy. XV. The long-term incidence of macular edema //Ophthalmology. - 1995. - Vol. 102. - P. 7-16.

    102. Klein R., Knudtson M.D., Lee K.E. et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes // Ophthalmology. - 2009. - Vol.116, №3. - P. 497 –503.

    103. Kwon Y.H., Lee D.K., Kwon O.W. The Short-term Efficacy of Subthreshold Micropulse Yellow (577-nm) Laser Photocoagulation for Diabetic Macular Edema. // Korean J Ophthalmol. - 2014. - Vol. 28, № 5. - P. 379-385.

    104. Landau D. Epithelial paracellular proteins in health and disease // Curr Opin Nephrol Hyperten. - 2006. - Vol. 15. - P. 425-429.

    105. Lanzetta P., Dorin G., Pirracchio A., Bandello F. Theoretical bases of nonophthalmoscopically visible endpoint photocoagulation // Semin Ophthalmol. - 2001. - Vol. 16, №1. - P. 8-11.

    106. Lavinsky D., Cardillo J.A., Melo L.A., Jr. et al. Randomized clinical trial evaluating mETDRS versus normal or high-density micropulse photocoagulation for diabetic macular edema // Invest Ophthalmol Vis Sci. - 2011. - Vol. 52, № 7. - P.4314-4323.

    107. Lavinsky D., Sramek C., Wang J. et al. Subvisible retinal laser therapy: titration algorithm and tissue response // Retina. - 2013. - Vol. 34, № 1. - P. 87-97.

    108. Lecomte M., Denis U., Ruggiero D. et al, Involvement of caspase-10 in advanced glycation end-product-induced apoptosis of bovine retinal pericytes in culture // Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. - 2004. - Vol. 1689, № 3. - P. 202 –211.

    109. Lee R., Wong T.Y., Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss // Eye Vis (Lond). - 2015. – Vol. 30, №2. - P. 17.

    110. Lieth E., Barber A. J., Xu B. et al. Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy // Penn State Retina Research Group. Diabetes. - 1988. - Vol. 47. - P. 815 –820.

    111. Lieth E., LaNoue K.F., Antonetti D.A., Ratz M. Diabetes reduces glutamate oxidation and glutamine synthesis in the retina // The Penn State Retina Research Group. Exp. Eye Res. - 2000. - Vol. 70. - P. 723 –730.

    112. Lightman S., Towler H.M. Diabetic retinopathy // Clin Cornerstone. - 2003. - Vol. 5, №2. - P. 12 –21.

    113. Liu B.-F., Miyata S., Kojima H. et al. Low phagocytic activity of resident peritoneal macrophages in diabetic mice: relevance to the formation of advanced glycation end products // Diabetes. - Vol. 48, № 10. - P. 2074 –2082.

    114. Lovestam-Adrian M., Agardh E. Photocoagulation of diabetic macular oedema –complications and visual outcome // Acta Ophthalmol Scand. - 2000. - Vol .78. - P. 667-671.

    115. Lovestam-Adrian M., Holm K. Multifocal electroretinography amplitudes increase after photocoagulation in areas with increased retinal thickness and hard exudates. //Acta Ophthalmol. - 2010. - Vol. 88. - P. 188 –192.

    116. Luttrull J.K., Sinclair S.H. Safety of transfoveal subthreshold diode micropulse laser for fovea-involving diabetic macular edema in eyes with good visual acuity. //Retina. - 2014. - Vol 34, № 10. - P. 2010-2020.

    117. Marmor M.F. Mechanisms of fluid accumulation in retinal edema // Doc Ophthalmol. - 1999. - Vol. 97. - P. 239-249.

    118. Matsunaga N., Chikaraishi Y., Izuta H. et al. Role of Soluble Vascular Endothelial Growth Factor Receptor-1 in the Vitreous in Proliferative Diabetic Retinopathy // Ophthalmology. - 2008. - Vol. 115. - P. 1916-1922.

    119. Meyer-Schwickerath G., Schott K. Diabetic retinopathy and photocoagulation // Am. J. Ophthalmol. - 1968. - Vol. 66. - P. 597 –603.

    120. Miceli M.V., Liles M.R., Newsome D.A. Evaluation of oxidative processes in human pigment epithelial cells associated with retinal outer segment phagocytosis, // Experimental Cell Research. - 19994. - Vol. 214, № 1. - P. 242 –249.

    121. Miller S.S., Edelman J.L. Active ion transport pathways in the bovine retinal pigment epithelium // Journal of Physiology. - 1990. - Vol. 424. - P. 283 –300.

    122. Miura Y, Klettner A, Roider J. VEGF antagonists decrease barrier function of retinal pigment epithelium in vitro: possible participation of intracellular glutathione // Invest Ophthalmol Vis Sci. – 2010. – Vol. 51, № 9. – P. 4848-4855.

    123. Miyamoto K., Khosrof S., Bursell S.E. et al. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule -1 inhibition // Proct Natl Acad Sci U S A. - 1999. - Vol. 96. - P. 10836-10841.

    124. Moller F., Bek T. The relation between visual acuity, fixation stability, and the size and location of foveal hard exudates after photocoagulation for diabetic maculopathy: a 1-year follow-up study // Graefes Arch Clin Exp Ophthalmol. - 2003. - Vol. 241. - P. 458 –462.

    125. Mori K., Duh E., Gehlbach P., et al. Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization // J Cell Physiol. - 2001. - Vol. 188. - P. 253-263.

    126. Murakami T., Frey T., Lin C., Antonetti D.A. Protein kinase cβ phosphorylates occludin regulating tight junction trafficking in vascular endothelial growth factor-induced permeability in vivo // Diabetes. - 2012. - Vol. 61. - P. 1573 – 1583.

    127. Murakami T., Nishijima K., Sakamoto A. et al. Association of pathomorphology, photoreceptor status, and retinal thickness with visual acuity in diabetic retinopathy. // Am J Ophthalmol. - 2011. - Vol. 151. - P. 310 –317.

    128. Murata T., Nakagawa K., Khalil A. et al. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas // Lab Invest. - 1996. - Vol. 74. - P. 819-825.

    129. Nakamura Y., Mitamura Y., Ogata K. et al. Functional and morphological changes of macula after subthreshold micropulse diode laser photocoagulation for diabetic macular oedema // Eye (Lond). - 2010. - Vol. 24. - P. 784 –748.

    130. Newman E.A., Reichenbach A. The Muller cell: a functional element of the retina. Trends Neurosci. - 1996. - Vol. 19. - P. 307-317.

    131. Newsome D.A., Miceli M.V., Liles M.R. et al. Antioxidants in the retinal pigment epithelium // Progress in Retinal and Eye Research. - 1994. - Vol. 13, № 1. -P. 101 –123.

    132. Ng Y.K., Zeng X.X., Ling E.A. Expression of glutamate receptors and calcium-binding proteins in the retina of streptozotocin-induced diabetic rats // Brain Res. - 2004. - Vol. 1018. - P. 66 –72.

    133. Nguyen-Legros J., Hicks D. Renewal of photoreceptor outer segments and their phagocytosis by the retinal pigment epithelium // International. - 2000. - Vol. 196. - P. 245 –313.

    134. Nishijima K., Ng Y.-S., Zhong L., Bradley J. et al. VEGF-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptative response to ischemic injury // Am I Pathol. - 2007. - Vol. 171, № 1. - P. 53-67.

    135. Nittala M.G., Gella L., Raman R. Measuring retinal sensitivity with the microperimeter in patients with diabetes // Retina. - 2012. - Vol. 32. - P.1302 –1309.

    136. Ogata N., Ando N., Uyama M., Matsumura M. Expression of cytokines and transcription factors in photocoagulated human retinal pigment epithelial cells // Graefes Arch Clin Exp Ophthalmol. - 2001. - Vol .239. - P. 87 –95.

    137. Ogata N., Nishikawa M., Nishimura T. Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy // Am J Ophthalmol. - 2002. - Vol. 134. - P. 348-353.

    138. Ogata N., Tombran-Tink J., Jo N. et al. Upregulation of pigment epitheliumderived factor after laser photocoagulation // Am. J. Ophthalmol. – 2001. – Vol. 132, № 3. – P. 427-429.

    139. Ogata N., Tombran-Tink J., Nishikawa M. et al: Pigment epithelium-derived factor in the vitreous is low in diabetic retinopathy and high in rhegmatogenous retinal detachment // Am J Ophthalmol. - 2001. - Vol. 132. - P. 378-382.

    140. Okada K., Yamamoto S., Mizunoya S. Correlation of retinal sensitivity measured with fundus-related microperimetry to visual acuity and retinal thickness in eyes with diabetic macular edema // Eye. - 2006. - Vol. 20. - P. 805 –809.

    141. Oliver P.D., Newsome D.A. Mitochondrial superoxide dismutase in mature and developing human retinal pigment epithelium // Investigative Ophthalmology and Visual Science. - 1992. - Vol. 33, № 6. - P. 1909 –1918.

    142. Osborne N.N., Casson R.J., Wood J.P. et al, Retinal ischemia: mechanisms of damage and potential therapeutic strategies // Prog Retin Eye Res. - 2004. - Vol. 23, № 1. - P. 91-147.

    143. Otani T., Kishi S., Maruyama Y. Patterns of diabetic macular edema with optical coherence tomography // Am J Ophthalmol. - 1999. - Vol. 127, № 6. - P. 688-689.

    144. Ozaki H., Yu A.Y., Delia N. Hypoxia inducible factor-1 alpha is increased in ischemic retina: temporal and spatial correlation with VEGF // Invest Ophthalmol Vis Sei. - 1999. - Vol. 40. - P. 182-189.

    145. Pankratov M. Pulsed delivery of laser energy in experimental thermal retinal photocoagulation // Proc. Soc. Photo-Optical Instrum. Eng. – 1990. – Vol. 1202. – P. 205-213.

    146. Pannicke T., Iandiev I., Uckermann O. et al. A potassium channel-linked mechanism of glial cell swelling in the postischemic retina // Molecular and Cellular Neuroscience, - 2004. - Vol. 26, № 4. - P. 493 –502.

    147. Pannicke T., Iandiev I., Wurm A. et al. Diabetes alters osmotic swelling characteristics and membrane conductance of glial cells in rat retina // Diabetes. -2006. - Vol. 55, № 3. - P. 633 –639.

    148. Patz A. Clinical and experimental studies on retinal neovascularization // Am J Ophthalmol. - 1982. - Vol. 94. - P. 715-743.

    149. Pavlin C.J., Harasiewicz K., Sherar M.D., Foster F.S. Clinical use of ultrasound biomicroscopy. Ophthalmology // 1991. - Vol. 98, № 3. - P. 287-295.

    150. Pece A., Isola V., Holz F. Autofluorescence imaging of cystoid macular edema in diabetic retinopathy // Ophthalmologica. - 2010. - Vol. 224. - P. 230-235.

    151. Pulido J.E., Pulido J.S., Erie J.C. et al. A role for excitatory amino acids in diabetic eye disease // Exp. Diabetes Res. - 2007. - Vol. 2007, № 36150.

    152. Roider J., Brinkmann R., Wirbelauer C. Subthreshold (retinal pigment epithelium) photocoagulation in macular diseases: a pilot study // Br J Ophthalmol. -2000. - Vol. 84, №1. - P. 40 –47.

    153. Roider J., Liew S.H., Klatt C. et al. Selective retina therapy (SRT) for clinically significant diabetic macular edema // Graefe’s Archive for Clinical and Experimental Ophthalmology. - 2010. - Vol. 248, № 9. - P. 1263 –1272.

    154. Roider J., Michaud N.A., Flotte T.J., Birngruber R. Response of the retinal pigment epithelium to selective photocoagulation // Arch Ophthalmol. - 1992. - Vol. 110. - P. 1786 –1792.

    155. Romero-Aroca P., Riva-Fernandez de la S., Valls-Mateu A. et al. Changes observed in diabetic retinopathy: eight-year follow-up of a Spanish population // Br J Ophthalmol. – 2016. - January 14.

    156. Rungger-Brandle E., Dosso A.A., Leuenberger P.M. Glial reactivity, an early feature of diabetic retinopathy // Invest Ophthalmol Vis Sei. - 2000. - Vol. 4. -P. 1971-1980.

    157. Saint-Geniez M., Maldonado A.E., D'Amore P.A. VEGF expression and receptor activation in the choroid during development and in the adult // Invest Ophthalmol Vis Sei. - 2006. - Vol. 47. - P. 3135-3142.

    158. Sakai H., Tani Y., Shirasawa E. et al. Development of electroretinographic alterations in streptozotocin-induced diabetes in rats // Ophthalmic Res. - 1995. - 27. - P. 57-63.

    159. Santiago A.R., Gaspar J.M., Baptista F.I. et al. Diabetes changes the levels of ionotropic glutamate receptors in the rat retina // Mol. Vis. - 2009. - Vol. 15. - P. 1620 –1630.

    160. Schatz H., Madeira D., McDonald H.R., Johnson R.N. Progressive enlargement of laser scars following grid laser photocoagulation for diffuse diabetic macular edema // Arch Ophthalmol. - 1991. - Vol. 109, № 11. - P. 1549 –1551.

    161. Schatz H., Patz A. Cystoid maculopathy in diabetics // Arch. Ophthalmol. -1976. - Vol. 94. - P. 761 –768.

    162. Schmitz-Valckenberg S., Holz F.G., Bird A.C., Spaide R.F. Fundus autofluorescence imaging: review and perspectives // Retina. - 2008. - Vol 28. - P. 385-409.

    163. Schroder S., Palinski W., Schmid-Schonbein G.W. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in daibetic retinopathy // Am J Pathol. - 1991. - Vol. 139. - P. 81-100.

    164. Scott A.W., Bressler N.M. Update on the diabetic retinopathy clinical research network // Retina today. - 2008. - Vol. 3, №5. - P. 49 –52.

    165. Shweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis // Nature. - 1992. -Vol. 359. - P. 843-845.

    166. Simo R., Carrasco E., Garcia.Ramirez M., Hernandez C. Angiogenic and antiangiogenic factors in proliterative diabetic retinopathy // Curr Diabet Rev. - 2006. - Vol. 2. - P. 71-98.

    167. Simo R., Hernandez C. Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives // Trends Endocrinol Metabolism. - 2014. - Vol. 25. - P. 23-33.

    168. Simo R., Villarroel M., Corraliza L. et al. The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier - implications for the pathogenesis of diabetic retinopathy // J Biomed Biotechnol. - 2010. - Vol. 2010. - P. 190724-190739.

    169. Sinclair S.H., Nessler C., Foxman B. et al. Macular edema and pregnancy in insulin-dependent diabetes // Am J Ophthalmol. - 1984. - Vol. 97. - P. 154 –167.

    170. Singh R., Barden A., Mori T., Beilin L. Advanced glycation end-products: A review // Diabetologia. - 2001. - Vol. 44. - P. 129-146.

    171. Sivaprasad S., Sandhu R., Tandon A. et al. Subthreshold micropulse diode laser photocoagulation for clinically significant diabetic macular oedema: a three-year follow-up // Clin Experiment Ophthalmol. - 2007. - Vol. 35, № 7. - P. 640-644.

    172. Soliman W., Hasler P., Sander B. Local retinal sensitivity in relation to specific retinopathy lesions in diabetic macular oedema // Acta Ophthalmol. - 2010. -Vol. 90. - P. 248 –253.

    173. Soliman W., Sander B., Hasler P.W., Larsen M. Correlation between intraretinal changes in diabetic macular oedema seen in fluorescein angiography and optical coherence tomography // Acta Ophthalmol. - 2008. - Vol. 86, № 1. - P. 34-39.

    174. Soliman W., Sander B., Soliman K.A. et al. The predictive value of optical coherence tomography after grid laser photocoagulation for diffuse diabetic macular oedema // Acta Ophthalmol (Copenh). - 2008. - Vol. 86. - P. 284 –291.

    175. Spaide R. Autofluorescence from the outer retina and subretinal space: hypothesis and review // Retina. - 2008. - Vol. 28. - P. 5-35.

    176. Spranger J., Osterhoff M., Reimann M. et al. Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease // Diabetes. - 2001. - Vol. 50, № 12. - P.2641-2645.

    177. Steinberg R.H. Interactions between the retinal pigment epithelium and the neural retina // Documenta Ophthalmologica. - 1985. - Vol. 60, № 4. - P. 327 –346.

    178. Stellmach V. Crawford S.E., Zhou W., Bouck N. Prevention of ischaemiainduced retinopathy by the natural ocular antiangiogenic agent pigment epitheliumderived factor // Proc NatL Acad Soc USA. - 2001. - Vol. 98. - P. 2593-2597.

    179. Stewart P.A., Tuor U.I. Blood-eye barriers in the rat: correlation of ultrastructure with function //J Comp Neurol. - 1994. - Vol. 340. - P. 566-576.

    180. Stratton I.M., Kohner E.M., Aldington S.J. et al. UKPDS 50: risk factors for incidence and progression of diabetic retinopathy in type 2 diabetes over 6 years from diagnosis // Diabetologia. - 2001. - Vol. 44, № 2. - P. 56 –163.

    181. Strauss O. The retinal pigment epithelium in visual function // Physiological Reviews. - 2005. - Vol. 85, № 3. - P. 845 –881.

    182. Strom C., Sander B., Larsen N. et al. Diabetic macular edema assessed with optical coherence tomography and stereo fundus photography // Invest Ophthalmol Vis Sci. - 2012. - Vol. 43. - P. 241 –245.

    183. Sun J.K., Radwan S.H., Soliman A.Z. Neural Retinal Disorganization as a Robust Marker of Visual Acuity in Current and Resolved Diabetic Macular Edema. //Diabetes. - 2015. - Vol. 64, № 7. - P. 2560-2570.

    184. Tate D.J., Jr., Miceli M.V., Newsome D.A. Phagocytosis and H2O2 induce catalase and metallothionein gene expression in human retinal pigment epithelial cells // Investigative Ophthalmology and Visual Science. - 1995. - Vol. 36, № 7. - P. 1271 – 1279.

    185. Tehrani N.M., Riazi-Esfahani H., Jafarzadehpur E. et al. Multifocal Electroretinogram in Diabetic Macular Edema: Correlation with Visual Acuity and Optical Coherence Tomography // J Ophthalmic Vis Res. - 2015. - Vol. 10, № 2. - P. 165 –171.

    186. Tombran-Tink J., Chader G.J., Johnson L.V. PEDF: A pigment epitheliumderived factor with potent neuronal differentiative activity // Exp Eye Res. - 1991. - Vol .53. - P. 411-414.

    187. Tombran-Tink J., Johnson L.V. Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells // Invest Ophthalmol VisSci. - l989. - Vol. 30. - P. 1700-1707.

    188. Tong L., Vernon S.A., Kiel W. et al. Association of macular involvement with proliferative retinopathy in type 2 diabetes // Diabet Med. - 2001. - Vol. 18, №5. - P. 388 –394.

    189. Tout S., Chang-Ling T., Hollander H., Stone J. The role of Muller cells in the formation of the blood-retinal barrier // Neuroscience. - 1993. - Vol. 55. - P. 291-301.

    190. Tsao Y.P., Ho T.C., Chen S.L., Cheng H.C. Pigment epithelium-derived factor inhibits oxidative stress-induced cell death by activation of extracellular signalregulated kinases in cultured retinal pigment epithelial cells // Life Sciences. – 2006. – Vol. 79. – P. 545 –550.

    191. Tso M.O., Cunha-Vaz J.G., Shih C.Y., Jones C.W. Clinicopathologic study of blood-retinal barrier in experimental diabetes mellitus // Arch Ophthalmol. - 1980. - Vol. 98, № 11. - P. 2032-2040.

    192. Virgili G., Menchini F., Murro V. et al. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy // Cochrane Database Syst Rev. - 2011. - №7.

    193. Vujosevic S., Bottega E., Casciano M. et al. Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation. //Retina. - 2010. - Vol 30, № 6. - P. 908 –916.

    194. Vujosevic S., Casciano M., Pilotto E. et al. Diabetic macular edema: fundus autofluorescence and functional correlations // Invest Ophthalmol Vis Sci. - 2011. -Vol. 52. - P. 442-448.

    195. Vujosevic S., Martini F., Longhin E. et al. Subthreshold micropulse yellow laser versus subthreshold micropulse infrared laser in center-involving diabetic macular edema: morphologic and functional safety // Retina. - 2015. - Vol. 35, № 8. -P. 1594-1603.

    196. Vujosevic S., Midena E. Retinal layers changes in human pre-clinical and early clinical diabetic retinopathy supports early retinal neuronal and Muller cells alterations // J Diabetes Res. - 2013. - Vol. 2013. - Article ID 905058, 8 pages

    197. Vujosevic S., Midena E., Pilotto E. et al. Diabetic macular edema: correlation between microperimetry and optical coherence tomography findings // Invest Ophthalmol Vis Sci. - 2006. - Vol. 47. - P. 3044 –3051.

    198. Vujosevic S., Pilotto E., Bottega E. et al. Retinal fixation impairment in diabetic macular edema // Retina. - 2008. - Vol. 10. - P. 1443 –1450.

    199. Webb R.H., Hughes G.W., Delori F.C. Confocal scanning laser ophthalmoscope // Applied Optics. - 1987. - Vol. 26. - P. 1492-1499.

    200. Wong H.C., Boulton M., McLeod D., et al. Retinal pigment epithelial cells in culture produce retinal vascular mitogens // Arch Ophthalmol. - 1988. - Vol. 106, № 10. - P. 1439-1443.

    201. Wong R.L., Lee J.W., Yau G.S., Wong I.Y. Relationship between Outer Retinal Layers Thickness and Visual Acuity in Diabetic Macular Edema // Biomed Res Int. – 2015. - Vol 2015. - Article ID 981471, 5 pages

    202. Wong T.Y., Mwamburi M., Klein R. et al. Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis // Diabetes Care. - 2009. - Vol. 32, № 12. - P. 2307 –2313.

    203. Xiao C., He M., Nan Y. et al. Physiological effects of superoxide dismutase on altered visual function of retinal ganglion cells in db/db mice // PLoS One. - 2012. - Vol. 7, №1. - P. 1-10.

    204. Yamagishi S., Abe R., Jinnouchiet Y. et al. Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species - mediated vascular endothelial growth factor expression // J Biol Chem. - 2006. - Vol. 281, № 29. - P. 20213 –20220.

    205. Yamagishi S., Takeuchi M., Matsui T. et al. Angiotensin II augments advanced glycation end product-induced pericyte apoptosis through RAGE overexpression // FEBS Lett. - 2005. - Vol. 579. - P. 4265 –4270.

    206. Yang X.L., Zou H.D., Xu X. Correlation of retinal sensitivity, visual acuity and central macular thickness in different types of diabetic macular edema // Zhonghua Yan Ke Za Zhi. - 2013. - Vol. 49, № 12. - P. 1081-1088.

    207. Yinchen S., Xun X., Kun L. Fundus autofluorescence characteristics in patients with diabetic macular edema // Chin Med J. - 2014. - Vol. 127. -P. 1423- 1428.

    208. Yu A.K., Merrill K.D., Truong S.N. et al. The comparative histologic effects of subthreshold 532- and 810-nm diode micropulse laser on the retina // Invest Ophthalmol Vis Sci. - 2013. - Vol. 54, № 3. - P. 2216-2224.

    209. Yuuki T., Kanda T., Kimura Y. et al. Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy // J Diabetes Complications. - 2001. - Vol. 15. - P. 257-259.

    210. Zhang S.X., Wang J.J., Gao G., et al. Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor // FASEB J. - 2006. - Vol. 20, № 2. - P. 323 –325.